In the article “Monitoring of radiologic disease activity by serum neurofilaments in MS” by Uher et al.,1 the following sentence was omitted from the Study Funding statement: “The project was also funded by International Mobility of Researchers at Charles University (reg. n. CZ.02.2.69/0.0/0.0/16_027/0008495) supported by the Operational Programme Research, Development and Education.” The authors regret the error.
- © 2020 American Academy of Neurology
Reference
- 1.↵
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Neurofilament light as a biomarker in traumatic brain injury
Serum neurofilament light is sensitive to active cerebral small vessel disease